发明名称 |
Tetracycline compositions |
摘要 |
The present invention relates to compositions, pharmaceutical compositions, and methods for preparing the same, comprising a tetracycline with improved stability and solubility. Some embodiments include a tetracycline with an excess of a divalent or trivalent cation. |
申请公布号 |
US9084802(B2) |
申请公布日期 |
2015.07.21 |
申请号 |
US201414204881 |
申请日期 |
2014.03.11 |
申请人 |
REMPEX PHARMACEUTICALS, INC. |
发明人 |
Griffith David C.;Boyer Serge;Hecker Scott;Dudley Michael N. |
分类号 |
A01N47/00;A61K31/21;A61K31/65;A61K9/00;A61K47/02 |
主分类号 |
A01N47/00 |
代理机构 |
Knobbe Martens Olson & Bear LLP |
代理人 |
Knobbe Martens Olson & Bear LLP |
主权项 |
1. A method of treating a bacterial infection in a subject, wherein the method consists of:
administering a therapeutically effective amount of a composition to a subject in need thereof via an intravenous route of administration, wherein the composition consists of an aqueous solution consisting of minocycline or a salt thereof, a salt that comprises a magnesium cation, and a base, wherein the molar ratio of magnesium cation to minocycline is greater than about 4:1, and wherein the composition has a pH that is no less than 4 and no greater than 6, whereby injection site hemolysis of red blood cells is reduced relative to intravenous administration of a composition that does not include magnesium. |
地址 |
San Diego CA US |